Novartis Investigative Site

Monaco 98000

0 studies enrolling now · 3 studies all time

What they study most

Ankylosing Spondylitis, Heart Failure With Reduced Ejection Fraction (HF-rEF), Non-radiographic Spondyloarthritis

Studies at this site

• Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) — Completed
• Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis — Completed
• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE